Moreover, metabolic alterations such as disrupted fatty acid and tryptophan metabolism and heightened systemic inflammation (elevated IL-6, C-reactive protein) distinguish post-TB COPD from tobacco-related COPD, underscoring the unique nature of this disease subset. This evidence concerns the gene IL6 and chronic obstructive pulmonary disease.